Capital Group Private Client Services Inc. lessened its stake in Danaher Corporation (NYSE:DHR – Free Report) by 7.4% during the fourth quarter, HoldingsChannel reports. The firm owned 48,726 shares of the conglomerate’s stock after selling 3,873 shares during the period. Capital Group Private Client Services Inc.’s holdings in Danaher were worth $11,154,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds also recently modified their holdings of the stock. Tradition Wealth Management LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $226,000. Modus Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth approximately $50,000. Greykasell Wealth Strategies Inc. bought a new stake in shares of Danaher in the 4th quarter worth approximately $46,000. Lowe Brockenbrough & Co. Inc. raised its holdings in shares of Danaher by 32.7% in the 4th quarter. Lowe Brockenbrough & Co. Inc. now owns 4,082 shares of the conglomerate’s stock worth $934,000 after purchasing an additional 1,006 shares during the period. Finally, MCF Advisors LLC raised its holdings in shares of Danaher by 24.7% in the 4th quarter. MCF Advisors LLC now owns 1,112 shares of the conglomerate’s stock worth $255,000 after purchasing an additional 220 shares during the period. Institutional investors own 79.05% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on DHR shares. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price on the stock. Argus lowered their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. UBS Group lowered their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $235.14.
Danaher Stock Down 1.2%
DHR opened at $184.45 on Friday. The company has a fifty day moving average price of $181.29 and a 200-day moving average price of $206.19. The firm has a market capitalization of $130.55 billion, a P/E ratio of 35.68, a price-to-earnings-growth ratio of 2.46 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the business earned $1.88 EPS. Equities research analysts expect that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is 30.95%.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
